633. Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-Existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinica...

por D’Antoni, Michelle L, Andreatta, Kristen, Acosta, Rima K, Chang, Silvia, Martin, Ross, White, Kirsten L
Publicado 2020

888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence

por Acosta, Rima K, Mulato, Andrew, D’Antoni, Michelle L, Yant, Stephen R, Cihlar, Tomas, White, Kirsten L
Publicado 2021

Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials

por D'Antoni, Michelle L., Andreatta, Kristen, Acosta, Rima, Martin, Hal, Chang, Silvia, Martin, Ross, White, Kirsten L.
Publicado 2022

Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro

por Acosta, Rima K., D’Antoni, Michelle L., Mulato, Andrew, Yant, Stephen R., Cihlar, Tomas, White, Kirsten L.
Publicado 2022

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

por Andreatta, Kristen, D’Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2020

1561. Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Versus Dolutegravir (DTG)-Based 3-Drug Regimens in Adults With HIV Who Have Suboptimal Antiretroviral Ad...

por Andreatta, Kristen, Sax, Paul E, Wohl, David Alain, D’Antoni, Michelle L, Huang, Hailin, Hindman, Jason, Callebaut, Christian, Martin, Hal
Publicado 2023

629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Su...

por Andreatta, Kristen, D'Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Martin, Ross, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2021

Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness

por SahBandar, Ivo N., Ndhlovu, Lishomwa C., Saiki, Katelyn, Kohorn, Lindsay B., Peterson, Mary Margaret, D'Antoni, Michelle L., Shiramizu, Bruce, Shikuma, Cecilia M., Chow, Dominic C.
Publicado 2020

Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment

por de Menezes, Erika G. Marques, Liu, Jocelyn S., Bowler, Scott A., Giron, Leila B., D’Antoni, Michelle L., Shikuma, Cecilia M., Abdel-Mohsen, Mohamed, Ndhlovu, Lishomwa C., Norris, Philip J.
Publicado 2022

IL-1Β Enriched Monocytes Mount Massive IL-6 Responses to Common Inflammatory Triggers among Chronically HIV-1 Infected Adults on Stable Anti-Retroviral Therapy at Risk for Cardiova...

por Jalbert, Emilie, Crawford, Timothy Q., D’Antoni, Michelle L., Keating, Sheila M., Norris, Philip J., Nakamoto, Beau K., Seto, Todd, Parikh, Nisha I., Shikuma, Cecilia M., Ndhlovu, Lishomwa C., Barbour, Jason D.
Publicado 2013

Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection

por D'Antoni, Michelle L., Kallianpur, Kalpana J., Premeaux, Thomas A., Corley, Michael J., Fujita, Tsuyoshi, Laws, Elizabeth I., Ogata-Arakaki, Debra, Chow, Dominic C., Khadka, Vedbar S., Shikuma, Cecilia M., Ndhlovu, Lishomwa C.
Publicado 2019

Comparative DNA Methylation Profiling Reveals an Immunoepigenetic Signature of HIV-related Cognitive Impairment

por Corley, Michael J., Dye, Christian, D’Antoni, Michelle L., Byron, Mary Margaret, Yo, Kaahukane Leite-Ah, Lum-Jones, Annette, Nakamoto, Beau, Valcour, Victor, SahBandar, Ivo, Shikuma, Cecilia M., Ndhlovu, Lishomwa C., Maunakea, Alika K.
Publicado 2016

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years...

por Maggiolo, Franco, Rizzardini, Giuliano, Molina, Jean‐Michel, Pulido, Federico, De Wit, Stephane, Vandekerckhove, Linos, Berenguer, Juan, D'Antoni, Michelle L., Blair, Christiana, Chuck, Susan K., Piontkowsky, David, Martin, Hal, Haubrich, Richard, McNicholl, Ian R., Gallant, Joel
Publicado 2022

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

por Maggiolo, Franco, Rizzardini, Giuliano, Molina, Jean-Michel, Pulido, Federico, De Wit, Stephane, Vandekerckhove, Linos, Berenguer, Juan, D’Antoni, Michelle L., Blair, Christiana, Chuck, Susan K., Piontkowsky, David, Martin, Hal, Haubrich, Richard, McNicholl, Ian R., Gallant, Joel
Publicado 2021

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

por Sax, Paul E., Andreatta, Kristen, Molina, Jean-Michel, Daar, Eric S., Hagins, Debbie, Acosta, Rima, D’Antoni, Michelle L., Chang, Silvia, Martin, Ross, Liu, Hui, Blair, Christiana, McNicholl, Ian, Gallant, Joel, Collins, Sean E., Martin, Hal, White, Kirsten L.
Publicado 2022

1611. Real-World Effectiveness and Tolerability of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People With HIV and a History of Antiretrovira...

por Trottier, Benoit, Bonnet, Fabrice, Garcia-Deltoro, Miguel, Andreoni, Massimo, Boffito, Marta, van Welzen, Berend J, Turner, Dan, McConkey, Sam, Watanabe, Dai, Lu, Po-Liang, Gündüz, Alper, Thorpe, David, D’Antoni, Michelle L, Cassidy, Tali, Marongiu, Andrea, Weinberg, Amy R, Haubrich, Richard, Scholten, Stefan
Publicado 2023